See more : XSport Global, Inc. (XSPT) Income Statement Analysis – Financial Results
Complete financial analysis of Enfusion, Inc. (ENFN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Enfusion, Inc., a leading company in the Software – Application industry within the Technology sector.
- All World Resources Corporation (AWRS) Income Statement Analysis – Financial Results
- The Dixie Group, Inc. (DXYN) Income Statement Analysis – Financial Results
- CLC Industries Limited (SPENTEX.BO) Income Statement Analysis – Financial Results
- Gold Standard Ventures Corp (GSV) Income Statement Analysis – Financial Results
- Bancorp 34, Inc. (BCTF) Income Statement Analysis – Financial Results
Enfusion, Inc. (ENFN)
About Enfusion, Inc.
Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It provides portfolio management system, which generates a real-time investment book of record that consists of valuation and risk tools that allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and order and execution management system that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. The company also offers accounting/general ledger system, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion analytics system, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion Inc. was incorporated in 2021 and is headquartered in Chicago, Illinois.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 174.54M | 150.35M | 111.70M | 79.57M | 59.03M |
| Cost of Revenue | 57.64M | 47.10M | 31.85M | 21.36M | 16.96M |
| Gross Profit | 116.89M | 103.25M | 79.86M | 58.21M | 42.07M |
| Gross Profit Ratio | 66.97% | 68.67% | 71.49% | 73.16% | 71.27% |
| Research & Development | 19.89M | 17.16M | 153.40M | 6.32M | 4.15M |
| General & Administrative | 64.64M | 68.76M | 150.61M | 35.89M | 16.63M |
| Selling & Marketing | 20.42M | 29.29M | 51.73M | 9.93M | 7.43M |
| SG&A | 85.05M | 98.05M | 202.34M | 45.82M | 24.05M |
| Other Expenses | 0.00 | -638.00K | -1.19M | 82.00K | -3.00K |
| Operating Expenses | 104.95M | 115.21M | 355.74M | 52.13M | 28.20M |
| Cost & Expenses | 162.59M | 162.31M | 387.58M | 73.49M | 45.16M |
| Interest Income | 0.00 | 413.00K | 4.59M | 1.66M | 724.00K |
| Interest Expense | 0.00 | 413.00K | 4.59M | 1.66M | 724.00K |
| Depreciation & Amortization | 9.99M | 6.60M | 3.98M | 2.29M | 1.16M |
| EBITDA | 21.94M | -5.62M | -271.91M | 8.37M | 15.02M |
| EBITDA Ratio | 12.57% | -3.74% | -244.49% | 10.62% | 25.45% |
| Operating Income | 11.95M | -11.96M | -275.88M | 6.07M | 13.87M |
| Operating Income Ratio | 6.85% | -7.96% | -246.99% | 7.63% | 23.50% |
| Total Other Income/Expenses | -464.00K | -225.00K | -5.78M | -1.58M | -727.00K |
| Income Before Tax | 11.48M | -12.19M | -281.66M | 4.49M | 13.14M |
| Income Before Tax Ratio | 6.58% | -8.11% | -252.16% | 5.65% | 22.26% |
| Income Tax Expense | 2.23M | 1.07M | 579.00K | 433.00K | 486.00K |
| Net Income | 6.03M | -13.26M | -282.24M | 4.06M | 12.66M |
| Net Income Ratio | 3.45% | -8.82% | -252.68% | 5.10% | 21.44% |
| EPS | 0.10 | -0.16 | -4.30 | 0.04 | 0.11 |
| EPS Diluted | 0.07 | -0.16 | -4.30 | 0.04 | 0.11 |
| Weighted Avg Shares Out | 88.20M | 85.39M | 65.58M | 113.05M | 113.05M |
| Weighted Avg Shares Out (Dil) | 129.43M | 85.39M | 65.58M | 113.05M | 113.05M |
Enfusion (ENFN) Moves 5.0% Higher: Will This Strength Last?
The Schall Law Firm Is Investigating Enfusion, Inc. For Possible Securities Fraud And Affected Shareholders Are Urged To Lend A Hand
Enfusion Inc May Have Violated Securities Laws And The Schall Law Firm Wants Investors With Losses To Help With An Inquiry
The Schall Law Firm Is Looking Into Enfusion, Inc. For Possible Securities Fraud And Shareholders Are Urged To Take Part
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Enfusion, Inc. - ENFN
Exclusive: Financial software maker Enfusion explores options including sale, sources say
Enfusion Inc May Have Violated Securities Regulations And The Schall Law Firm Encourages Investor Participation In An Inquiry
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Enfusion, Inc. - ENFN
The Schall Law Firm Is Looking Into Enfusion, Inc. For Possible Securities Fraud And Affected Stockholders Are Urged To Reach Out
Enfusion Inc May Have Violated Securities Laws And Investors With Losses Can Join The Schall Law Firm's Investigation
Source: https://incomestatements.info
Category: Stock Reports